Literature DB >> 25016060

Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression.

Paola Barboro1, Nicoletta Ferrari1, Cecilia Balbi2.   

Abstract

The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a nucleic acid-binding protein that serves as a docking platform integrating transduction pathways to nucleic acid -directed processes. Recently, this protein has emerged as an important player in carcinogenesis process. HnRNP K is overexpressed in several human cancers and its aberrant cytoplasmic localization has been associated with a worse prognosis for patients, suggesting that it has a role in cancer progression. Herein, we provide a brief overview of the multifunctional roles of hnRNP K and discuss clinical studies that have demonstrated its involvement in cancer development and progression.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Heterogeneous nuclear ribonucleoprotein K; Prognostic biomarker

Mesh:

Substances:

Year:  2014        PMID: 25016060     DOI: 10.1016/j.canlet.2014.06.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  49 in total

1.  GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.

Authors:  P Y Billie Au; Jing You; A Micheil Innes; Antonie D Kline; Oana Caluseriu; Jeremy Schwartzentruber; Jacek Majewski; Francois P Bernier; Marcia Ferguson; David Valle; Jillian S Parboosingh; Nara Sobreira
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

2.  Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.

Authors:  Chang Hoon Shin; Hong Lee; Hye Ree Kim; Kyung Hee Choi; Je-Gun Joung; Hyeon Ho Kim
Journal:  Cell Death Differ       Date:  2017-07-14       Impact factor: 15.828

Review 3.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

4.  Regulation of the p53 expression profile by hnRNP K under stress conditions.

Authors:  Agata Swiatkowska; Mariola Dutkiewicz; Piotr Machtel; Damian M Janecki; Martyna Kabacinska; Paulina Żydowicz-Machtel; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2020-05-29       Impact factor: 4.652

5.  Heterogeneous nuclear ribonucleoprotein K inhibits heat shock-induced transcriptional activity of heat shock factor 1.

Authors:  Hee-Jung Kim; Jae-Jin Lee; Jin-Hwan Cho; Jaeho Jeong; A Young Park; Wonmo Kang; Kong-Joo Lee
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

6.  Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.

Authors:  Miguel Gallardo; Prerna Malaney; Marisa J L Aitken; Xiaorui Zhang; Todd M Link; Vrutant Shah; Sanzhar Alybayev; Meng-Han Wu; Laura R Pageon; Huaxian Ma; Rodrigo Jacamo; Li Yu; Zijun Y Xu-Monette; Haley Steinman; Hun Ju Lee; Dos Sarbassov; Inmaculada Rapado; Michelle C Barton; Joaquin Martinez-Lopez; Carlos Bueso-Ramos; Ken H Young; Sean M Post
Journal:  J Natl Cancer Inst       Date:  2020-01-01       Impact factor: 13.506

7.  hnRNP K Is a Novel Internal Ribosomal Entry Site-Transacting Factor That Negatively Regulates Foot-and-Mouth Disease Virus Translation and Replication and Is Antagonized by Viral 3C Protease.

Authors:  Wenming Liu; Decheng Yang; Chao Sun; Haiwei Wang; Bo Zhao; Guohui Zhou; Li Yu
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

8.  MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.

Authors:  L Liu; C Luo; Y Luo; L Chen; Y Liu; Y Wang; J Han; Y Zhang; N Wei; Z Xie; W Wu; G Wu; Y Feng
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

9.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

Review 10.  Aberrant hnRNP K expression: All roads lead to cancer.

Authors:  Miguel Gallardo; Marisa J Hornbaker; Xiaorui Zhang; Peter Hu; Carlos Bueso-Ramos; Sean M Post
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.